The full income statement, balance sheet, and cash-flow statement for BeOne Medicines Ltd. American Depositary Shares (ONC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
Source: ONC's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ONC filings on SEC EDGAR → Not investment advice.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 5.34B YoY+40.2% | 3.81B YoY+55.0% | 2.46B YoY+73.7% | 1.42B YoY+20.4% | 1.18B YoY+280.8% | |
4.67B YoY+45.3% | 3.22B YoY+54.7% | 2.08B YoY+84.1% | 1.13B YoY+11.7% | 1.01B | ||
| Research & development | 2.15B YoY+9.9% | 1.95B YoY+9.8% | 1.78B YoY+8.4% | 1.64B YoY+12.4% | 1.46B YoY+12.7% | |
| Selling, general & administrative | 2.08B YoY+13.7% | 1.83B YoY+21.4% | 1.51B YoY+17.9% | 1.28B YoY+29.1% | 990M YoY+65.0% | |
| Amortization of intangibles | 10.1M YoY+108.8% | 4.82M YoY-33.4% | 7.24M YoY+82.1% | 3.98M YoY+131.8% | 1.72M YoY+102.7% | |
| Provision for credit losses | — | — | — | -219K YoY-170.9% | 309K YoY+183.5% | |
| Operating income | 447M YoY+178.7% | -568M YoY+53.0% | -1.21B YoY+32.5% | -1.79B YoY-24.4% | -1.44B YoY+13.2% | |
| Interest expense | 50.0M YoY+129.1% | 21.8M YoY+399.7% | 4.36M YoY-79.9% | 21.7M YoY-25.8% | 29.3M YoY+59.8% | |
| Interest & investment income | 70.5M YoY+1.2% | 69.6M YoY-11.1% | 78.4M | — | — | |
| Net interest income | — | — | 74.0M YoY+41.0% | 52.5M YoY+433.1% | -15.8M YoY-888.6% | |
| Other non-operating income | -42.6M YoY-236.7% | -12.6M YoY-104.1% | 308M YoY+237.5% | -224M YoY-1507.5% | 15.9M YoY-57.6% | |
| Equity-method income | — | — | -16.2M YoY+26.3% | -22.0M YoY-388.2% | 7.63M YoY-35.5% | |
| Gain (loss) on equity securities | -74.5M | — | — | — | — | |
| Pre-tax income | 417M YoY+178.2% | -533M YoY+35.5% | -826M YoY+57.9% | -1.96B YoY-36.3% | -1.44B YoY+11.1% | |
| Income tax | 130M YoY+16.2% | 112M YoY+100.1% | 55.9M YoY+30.6% | 42.8M YoY+122.5% | 19.2M YoY+84.9% | |
287M YoY+144.5% | -645M YoY+26.9% | -882M YoY+56.0% | -2.00B YoY-37.5% | -1.46B YoY+10.3% | ||
$2.47 YoY+140.4% | -$6.11 YoY+27.7% | -$8.45 YoY+56.4% | -$19.37 YoY-23.1% | -$15.73 YoY+19.3% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
6.23B YoY+56.2% | 3.99B YoY-5.0% | 4.20B YoY-19.3% | 5.21B YoY-31.6% | 7.61B YoY+53.5% | ||
8.19B YoY+38.3% | 5.92B YoY+2.0% | 5.81B YoY-9.0% | 6.38B YoY-25.3% | 8.54B YoY+52.4% | ||
1.83B YoY-17.4% | 2.21B YoY+22.4% | 1.81B YoY+23.3% | 1.47B YoY-8.2% | 1.60B YoY+48.8% | ||
3.83B YoY+47.9% | 2.59B YoY+14.1% | 2.27B YoY+13.6% | 2.00B YoY-16.9% | 2.40B YoY+38.8% | ||
4.36B YoY+30.9% | 3.33B YoY-5.8% | 3.54B YoY-19.3% | 4.38B YoY-28.5% | 6.13B YoY+58.5% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.13B YoY+901.8% | -141M YoY+87.8% | -1.16B YoY+22.7% | -1.50B YoY-15.2% | -1.30B YoY-1.2% | ||
-276M YoY+49.6% | -548M YoY-1013.9% | 60.0M YoY-94.4% | 1.08B YoY+68.1% | 641M YoY+120.2% | ||
1.06B YoY+447.7% | 193M YoY-53.6% | 416M YoY+2295.3% | -19.0M YoY-100.5% | 3.64B YoY-30.1% | ||
| FX effect on cash | 60.0M YoY+216.1% | -51.7M YoY-539.8% | -8.08M YoY+88.4% | -69.4M YoY-594.4% | 14.0M YoY-23.0% | |
| Net change in cash | 1.97B YoY+460.2% | -547M YoY+20.6% | -689M YoY-35.7% | -508M YoY-117.0% | 2.99B YoY+289.1% | |
| Interest paid | 34.4M YoY+74.6% | 19.7M YoY+466.1% | 3.48M YoY+15392.0% | 22.5K YoY-99.9% | 30.0M YoY-32.1% | |
| Income taxes paid | 101M YoY+45.0% | 69.4M YoY+24.0% | 56.0M YoY+89.8% | 29.5M YoY+88.0% | 15.7M YoY+48.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 33.7B YoY+71.0% | 19.7B YoY+4.5% | 18.9B YoY-17.4% | 22.8B YoY-17.9% | 27.8B YoY+17.5% | |
| P/E | 117.5× | — | — | — | — | |
| P/S | 6.3× YoY+21.9% | 5.2× YoY-39.5% | 8.6× YoY-53.2% | 18.3× YoY-22.7% | 23.6× YoY-69.1% | |
| P/B | 7.7× YoY+30.6% | 5.9× YoY+18.0% | 5.0× YoY+2.2% | 4.9× YoY+8.1% | 4.5× YoY-25.8% | |
| P/FCF | 35.8× | — | — | — | — | |
0.85% | — | — | — | — | ||
2.8% | — | — | — | — | ||
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
